Medical imaging technology provider Ixico (LON: IXI) did better than expected in the year to September 2026. Revenues are expected to be £8.3m, although the loss will still be higher than in 2024-25 because of investment to better exploit the existing technology. The order book is worth £16m. The share price jumped 16.1% to 9p.
Paper and advanced materials manufacturer James Cropper (LON: CRPR) says full year figures are expected to be better than currently forecast. The paper and packaging business performed strongly in the first half, helped by cost management. Full year EBITDA was expected to be £9.4m and the guided range has been raised to £10.3m to £11.3m. Interim results will be published in November. The share price gained 9.29% to 765p, which is 135% higher this year.
Nine-month oil revenues at the Sagebrush project in Colorado, where Quantum Helium (LON: QHE) has a 90% working interest, are higher than for the whole of 2025. This is providing income while the helium production is developed. Revenues have been $501,000, with the Quantum Helium share being $451,000, so far this year. There is a larger-volume stimulation programme planned for helium production at Sagebrush-1. The share price improved 6.67% to 1.6p.
Shares in antimicrobials developer Ondine Biomedical Inc (LON: OBI) returned from suspension following the completion of a £10m share issue at 10p/share. Chief executive Carolyn Cross invested £1.06m. The LANTERN phase 3 study for non-antibiotic nasal photodisinfection product Steriwave has been completed with positive topline results. This means that costs should reduce and spending move to regulatory approvals and commercial growth. There will be additional people hired. A pre-NDA meeting with the FDA could happen in the first quarter of 2027, followed by an NDA submission in mid-2027. The cash raised should last into 2028, but more cash will be required for the US launch, although that could come from bank debt or partnerships. The share price rose 5.13% to 10.25p. which is above the issue price.
Cyber security services provider Shearwater Group (LON: SWG) has announced a contract renewal ahead of next week’s 2025-26 results announcement – a pre-tax profit of £1.2m is forecast. The contract with a UK central government department has been expanded and is worth £1.7m over two years. The share price increased 2.88% to 71.5p.
FALLERS
Truetide (LON: TRUE) has corrected last week’s announcement about investee company Paraytec. The announcement concerned the evaluation of the feasibility of combining VosBio’s breath-collection technology with Paraytec’s CX300 platform in the field of early, non-invasive lung cancer detection. It included statements of things that have yet to happen and three of them have been removed from the updated version. No human samples have been taken or processed and instead it was simulated air samples that were used. The share price slumped 15.4%, having barely moved on the original announcement.
Musical instruments retailer Gear4Music (LON: G4M) says trading is in line with expectations with first half revenues growing by 6%, which represents a slowing in growth in the second quarter. Lack of one-off deals and investment in a new distribution centre mean that EBITDA has slipped from £6.5m to £5.7m. Last week founder and chief executive Andrew Wass won entrepreneur of the year at the 2026 AIM Awards. Interims will be announced on 17 November. The share price dipped 4.3% to 222.5p.
Metals Exploration (LON: MTL) says that there has been a fatal accident at the La India project construction site in Nicaragua. This happened during construction of a leach tank. The site has been closed and an investigation commenced. The share price declined 4.73% to 16.1p.